Psychedelic Therapy: Insights & Perspectives
Psychedelic therapy involves the guided use of psychedelic substances, such as ketamine, psilocybin or MDMA, in a therapeutic setting.
A trained therapist supports the patient through the experience, aiming to address specific psychological issues or enhance overall mental well-being. This method integrates preparation, the psychedelic experience, and post-session integration to facilitate deep psychological insights and emotional healing.
Getting Started With Insights & Perspectives
FREQUENTLY ASKED QUESTIONS
When did psychedelic therapy first emerge?
Psychedelic therapy first emerged in the mid-20th century, with research peaking in the 1950s and 1960s. It initially gained attention for its potential in treating alcoholism and other mental health disorders before legal restrictions curtailed its study and use.
What are the most common psychedelics used in therapeutic settings today?
Today, the most common psychedelics used in therapy include psilocybin (magic mushrooms), LSD, MDMA (ecstasy), and ketamine. Each has shown potential in treating various mental health conditions, from depression to PTSD.
What are the current regulations surrounding psychedelic therapy?
The legal status of psychedelic therapy varies by country and, in the U.S., by state. While substances like ketamine are legal for use in therapy, others like psilocybin and MDMA are currently undergoing clinical trials and are only available in research settings or through special programs.
